Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Optic fiber stocks tumble as US bans sales to Chinese telecom gear maker ZTE

US Commerce Department prohibits US companies from selling to Chinese telecom gear maker
Wires coming out of a tech system
Ban equally hurts US component companies betting on strong growth in China

Optical device makers tumbled broadly on Monday after the US Commerce Department banned US companies from selling their wares to Chinese telecom gear maker ZTE (SHE:000063) following a probe into illegally shipped equipment to Iran and North Korea.

Acacia Communications Inc (NASDAQ:ACIA) lost more than a third of its value, cratering nearly 36.8% to US$25.32, while Oclaro Inc (NASDAQ:OCLR) plummeted 12.5% in midday trading. Lumentum Holdings Inc. (NASDAQ: LITE) fell more than 6% to around US$60.38.

"ZTE made false statements to the U.S. government when they were originally caught and put on the Entity List (in 2016), made false statements during the reprieve it was given, and made false statements again during its probation," Secretary of Commerce Wilbur Ross said in a statement. "Instead of reprimanding ZTE staff and senior management, ZTE rewarded them. This egregious behavior cannot be ignored."

According to a Raymond James research note, Acacia gets nearly 30% of sales from ZTE, while Oclaro gets at least 14%. Lumentum, Finisar and NeoPhotonics get up to 3% of sales from ZTE, said the report. 

“The ZTE ban is uncategorical bad news for Acacia,” chimed in Loop Capital analyst James Kisner.

Applied Optoelectronics Inc (NASDAQ:AAOI), a major player in the telecom fiber optics group, fared a little better as it has limited exposure to ZTE.

AAOI shares were down 2% at US$29.58 on a day that its competitors fell much harder.      

"Perhaps there were other or bigger reasons behind the seven-year ban but the new actions seem harsh at first blush, hurting equally the U.S. component companies betting on strong growth in China," said Dmitry Netis, a William Blair analyst in a report cited by Investor’s Business Daily.  

View full PROAC profile View Profile

Proactiveinvestors Timeline

Related Articles

Cello
April 16 2018
Global pharmaceutical R&D is forecast to reach $182bn by 2022 having grown at near 4% annually since 2006
Lego
Wed
From an almost standing start in 2016, the group is scheduled to run Bricklive banded shows at 60 venues this year
Throne of Glass
April 30 2018
Rowling, Rowling, Rowling ... keep those titles rolling. Mind you, it's not all about Ms Rowling; Sarah J Maas title revenues grew 47% in the first half of the financial year and dieters are gorging on Tom Kerridge's books

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use